These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17336287)

  • 1. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques.
    Durán MC; Martín-Ventura JL; Mohammed S; Barderas MG; Blanco-Colio LM; Mas S; Moral V; Ortega L; Tuñón J; Jensen ON; Vivanco F; Egido J
    Eur J Pharmacol; 2007 May; 562(1-2):119-29. PubMed ID: 17336287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis.
    Martin-Ventura JL; Duran MC; Blanco-Colio LM; Meilhac O; Leclercq A; Michel JB; Jensen ON; Hernandez-Merida S; Tuñón J; Vivanco F; Egido J
    Circulation; 2004 Oct; 110(15):2216-9. PubMed ID: 15249501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human atheroma plaque secretome by proteomic analysis.
    Durán MC; Martín-Ventura JL; Mas S; Barderas MG; Dardé VM; Jensen ON; Egido J; Vivanco F
    Methods Mol Biol; 2007; 357():141-50. PubMed ID: 17172685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study.
    Cortellaro M; Cofrancesco E; Arbustini E; Rossi F; Negri A; Tremoli E; Gabrielli L; Camera M
    Thromb Haemost; 2002 Jul; 88(1):41-7. PubMed ID: 12152675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
    Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
    Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.
    Gómez-Hernández A; Sánchez-Galán E; Martín-Ventura JL; Vidal C; Blanco-Colio LM; Ortego M; Vega M; Serrano J; Ortega L; Hernández G; Tunón J; Egido J
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):60-9. PubMed ID: 16424787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G
    Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization.
    Abela GS; Vedre A; Janoudi A; Huang R; Durga S; Tamhane U
    Am J Cardiol; 2011 Jun; 107(12):1710-7. PubMed ID: 21507364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin.
    Muñoz-García B; Martín-Ventura JL; Martínez E; Sánchez S; Hernández G; Ortega L; Ortiz A; Egido J; Blanco-Colio LM
    Stroke; 2006 Aug; 37(8):2044-53. PubMed ID: 16809572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome.
    Park HK; Park EC; Bae SW; Park MY; Kim SW; Yoo HS; Tudev M; Ko YH; Choi YH; Kim S; Kim DI; Kim YW; Lee BB; Yoon JB; Park JE
    Circulation; 2006 Aug; 114(9):886-93. PubMed ID: 16923754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
    Buttmann M; Lorenz A; Weishaupt A; Rieckmann P
    J Neurochem; 2007 Aug; 102(4):1001-8. PubMed ID: 17442054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.
    Martín-Ventura JL; Tuñon J; Duran MC; Blanco-Colio LM; Vivanco F; Egido J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S189-93. PubMed ID: 17130260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
    Kato N; Liang YQ; Ochiai Y; Jesmin S
    Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin.
    Niessen J; Jedlitschky G; Grube M; Bien S; Schwertz H; Ohtsuki S; Kawakami H; Kamiie J; Oswald S; Starke K; Strobel U; Siegmund W; Rosskopf D; Greinacher A; Terasaki T; Kroemer HK
    Drug Metab Dispos; 2009 May; 37(5):1129-37. PubMed ID: 19237515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins.
    Katsargyris A; Klonaris C; Tsiodras S; Bastounis E; Giannopoulos A; Theocharis S
    Vascular; 2011 Dec; 19(6):320-6. PubMed ID: 21903856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.
    Blanco-Colio LM; Martín-Ventura JL; Muñóz-García B; Orbe J; Páramo JA; Michel JB; Ortiz A; Meilhac O; Egido J
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):916-22. PubMed ID: 17272745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine.
    Kim DE; Kim JY; Schellingerhout D; Shon SM; Jeong SW; Kim EJ; Kim WK
    Mol Imaging; 2009; 8(5):291-301. PubMed ID: 19796606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month.
    Martín-Ventura JL; Blanco-Colio LM; Gómez-Hernández A; Muñoz-García B; Vega M; Serrano J; Ortega L; Hernández G; Tuñón J; Egido J
    Stroke; 2005 Aug; 36(8):1796-800. PubMed ID: 16020773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.